GW Pharmaceuticals Plc Financials
Based on the key indicators related to GW Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, GW Pharmaceuticals Plc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in May.
With this module, you can analyze GWPRF financials for your investing period. You should be able to track the changes in GW Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
GWPRF |
Understanding current and past GW Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GW Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in GW Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in GW Pharmaceuticals' official financial statements usually reflect GW Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of GW Pharmaceuticals Plc. For example, before you start analyzing numbers published by GWPRF accountants, it's critical to develop an understanding of what GW Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the GWPRF space in which it operates.
Please note, the presentation of GW Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GW Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in GW Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GW Pharmaceuticals Plc. Please utilize our Beneish M Score to check the likelihood of GW Pharmaceuticals' management manipulating its earnings.
GW Pharmaceuticals Stock Summary
GW Pharmaceuticals competes with 51Talk Online, Lincoln Educational, Meta Data, Boyd Gaming, and Acco Brands. As of May 5, 2021, operates as a subsidiary of Jazz Pharmaceuticals plc. GW PHARMACEUTICALS is traded on OTC Exchange in the United States.Instrument | USA OTC Stock View All |
Exchange | OTCGREY Exchange |
ISIN | GB0030544687 |
Business Address | Sovereign House |
Benchmark | NYSE Composite |
Website | www.gwpharm.com |
Phone | 44 1223 266 800 |
Currency | USD - US Dollar |
You should never invest in GW Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of GWPRF OTC Stock, because this is throwing your money away. Analyzing the key information contained in GW Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
GW Pharmaceuticals Key Financial Ratios
Generally speaking, GW Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from GW Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of GW Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that GW Pharmaceuticals Plc reports annually and quarterly.Return On Equity | -9.62 | |||
Return On Asset | -4.58 | |||
Beta | 1.65 |
GWPRF Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GW Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare GW Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GW Pharmaceuticals competition to find correlations between indicators driving GW Pharmaceuticals's intrinsic value. More Info.GW Pharmaceuticals Plc is rated # 5 in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value GW Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GW Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GW Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in GWPRF OTC Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |